3 ms·
The reductions are absolutely coming from new treatments in particular immunotherapy. When I started Med school 19 years ago the average survival of metastatic
by robbiep 7y ago
The reductions are absolutely coming from new treatments in particular immunotherapy.
When I started Med school 19 years ago the average survival of metastatic melanoma was 6 months, it is now closer to 5 years (ie basically remission). Many other cancers (including lung, which this article pinpoints as being the main driver in falls over the last 12 months) are now benefiting from the second and third generation of these drugs